The Study “Effect of Cold Atmospheric Plasma on SARS‐CoV‐2”

We’re so proud to announce that the study our colleagues CEO Constantinos Loizou and Lab Director Theofylaktos Apostolou have been working on has been published in COVID peer-reviewed journal by one of the biggest academic publisher MDPI.

The study “Effect of Cold Atmospheric Plasma on SARS-CoV-2 Inactivation: A Pilot Study in the Hospital Environment” is dedicated to research on Cold atmospheric plasma (CAP) as  a new technology based on the emission in the air of reactive species neutral particles, UV radiation, and electromagnetic field.

In this study, an 80‐day clinical trial took place at Nicosia General Hospital to evaluate the application of CAP devices for lowering the viral load in the COVID rooms.

To overview the full document: Effect of Cold Atmospheric Plasma on SARS‐CoV‐2